In an attempt to secure the European Commission’s approval for its takeover of Bombardier's train manufacturing division, Alstom has offered to divest several product ranges and provide competitors with access to some of Bombardier’s on-board systems.
Competition enforcers in Australia and New Zealand have cleared Elanco Animal Health’s €7 billion acquisition of Bayer’s animal health business after Elanco agreed to divest several products in each country.
The UK’s antitrust enforcer has said it will ask the European Commission for permission to review the proposed merger between Virgin Media and O2 as the deal will only impact UK customers.
Drug purchasers suing generic pharmaceutical companies for an alleged antitrust conspiracy have told a federal judge that the case brought by a large group of state attorneys general centred on Teva Pharmaceuticals should be among the first to go to trial.
The antitrust agencies’ annual report to Congress on the Hart-Scott-Rodino deal-notification programme typically isn’t much of an occasion. This year things got interesting on two fronts: the report gave insight into whistleblower allegations that the Department of Justice investigated marijuana deals for non-competition reasons and Commissioner Rohit Chopra of the Federal Trade Commission issued a statement on the report saying anticompetitive “roll-up” deals are flying under the radar. There’s more on the HSR report in today’s Tipline, plus updates on bellwether trials for allegations of price-fixing by generic drugmakers and DOJ amicus participation in a utilities monopolisation case.
China’s State Administration for Market Regulation conditionally cleared three global deals between 19 February and 10 April. Charles McConnell explores what those clearances mean and how they fit into broader trends within the SAMR’s merger regime.
Most of the complaints that the UK’s Competition and Markets Authority receives stem from a past merger that has had subsequent market effects, the enforcer’s chief executive has said.
After more than three decades of working at the Competition Bureau of Canada as an economist, John Pecman stepped down last week as the Commissioner of Competition. He spoke with Pallavi Guniganti alongside McMillan partner James B Musgrove, who provided the private practitioner perspective, last month.
David Higbee, John Cove, Jessica Delbaum, Djordje Petkoski, Ryan Shores, Todd Stenerson and Mark Weiss
Tito Andrade, Maria Eugênia Novis de Oliveira and Marcos Paulo Verissimo
Fernando Carreño and Paloma Alcantra
Jesús Eloy Espinoza Lozada
Jacques Derenne and Dimitris Vallindas
Adina Claici and Elisa Pau
Connect with world leading experts at GCR Live